Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. / Hylenius, Sine; Andersen, Anne-Marie Nybo; Melbye, Mads; Hviid, Thomas Vauvert F.

In: Molecular Human Reproduction, Vol. 10, No. 4, 2004, p. 237-246.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hylenius, S, Andersen, A-MN, Melbye, M & Hviid, TVF 2004, 'Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads', Molecular Human Reproduction, vol. 10, no. 4, pp. 237-246. https://doi.org/10.1093/molehr/gah035

APA

Hylenius, S., Andersen, A-M. N., Melbye, M., & Hviid, T. V. F. (2004). Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Molecular Human Reproduction, 10(4), 237-246. https://doi.org/10.1093/molehr/gah035

Vancouver

Hylenius S, Andersen A-MN, Melbye M, Hviid TVF. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Molecular Human Reproduction. 2004;10(4):237-246. https://doi.org/10.1093/molehr/gah035

Author

Hylenius, Sine ; Andersen, Anne-Marie Nybo ; Melbye, Mads ; Hviid, Thomas Vauvert F. / Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. In: Molecular Human Reproduction. 2004 ; Vol. 10, No. 4. pp. 237-246.

Bibtex

@article{2912d2809f0011df928f000ea68e967b,
title = "Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads",
abstract = "Pre-eclampsia affects 2-7{\%} of all pregnancies with varying severity and is a leading cause of maternal and fetal mortality and morbidity. The aetiology involves almost certainly a combination of genetic predisposition with maternal and fetal contributions and environmental factors. Research points towards pathologies in the placenta as the triggering factor which leads to systemic endothelial dysfunction in the mother, probably as the result of interaction with released placental factors circulating in the maternal blood. One prominent hypothesis regarding the aetiology of pre-eclampsia suggests that it is caused by immune- maladaptation. The MHC class Ib gene, HLA-G, is expressed in the placenta and seems to have immunomodulatory functions. Aberrant HLA-G mRNA and protein expression in pre-eclamptic placentas have been reported. Here, we have investigated detailed HLA-G genotypes in a case-control study of 155 family triads of mother, father and newborn. Among primiparas, an overrepresentation of a homozygous HLA-G genotype was detected in the 40 pre-eclamptic offspring compared to the 70 controls [P = 0.002, Fisher's exact test; odds ratio 5.57 (95{\%} CI 1.79-17.31)]. Further analyses suggested that the differences between pre-eclamptic cases and controls primarily were accomplished by a different transmission from the father of a 14 bp deletion/insertion polymorphism in exon 8 (P = 0.006, Fisher's exact test), which previously has been linked to differences in the levels of HLA-G expression and in HLA-G mRNA splicing. The results may also indicate that combined mother-child HLA-G genotypes could influence the risk of developing pre-eclampsia. Overall, the study suggests that HLA-G genotypes and expression might have a significant influence on development of pre-eclampsia.",
author = "Sine Hylenius and Andersen, {Anne-Marie Nybo} and Mads Melbye and Hviid, {Thomas Vauvert F}",
year = "2004",
doi = "10.1093/molehr/gah035",
language = "English",
volume = "10",
pages = "237--246",
journal = "Molecular Human Reproduction",
issn = "1360-9947",
publisher = "Oxford University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads

AU - Hylenius, Sine

AU - Andersen, Anne-Marie Nybo

AU - Melbye, Mads

AU - Hviid, Thomas Vauvert F

PY - 2004

Y1 - 2004

N2 - Pre-eclampsia affects 2-7% of all pregnancies with varying severity and is a leading cause of maternal and fetal mortality and morbidity. The aetiology involves almost certainly a combination of genetic predisposition with maternal and fetal contributions and environmental factors. Research points towards pathologies in the placenta as the triggering factor which leads to systemic endothelial dysfunction in the mother, probably as the result of interaction with released placental factors circulating in the maternal blood. One prominent hypothesis regarding the aetiology of pre-eclampsia suggests that it is caused by immune- maladaptation. The MHC class Ib gene, HLA-G, is expressed in the placenta and seems to have immunomodulatory functions. Aberrant HLA-G mRNA and protein expression in pre-eclamptic placentas have been reported. Here, we have investigated detailed HLA-G genotypes in a case-control study of 155 family triads of mother, father and newborn. Among primiparas, an overrepresentation of a homozygous HLA-G genotype was detected in the 40 pre-eclamptic offspring compared to the 70 controls [P = 0.002, Fisher's exact test; odds ratio 5.57 (95% CI 1.79-17.31)]. Further analyses suggested that the differences between pre-eclamptic cases and controls primarily were accomplished by a different transmission from the father of a 14 bp deletion/insertion polymorphism in exon 8 (P = 0.006, Fisher's exact test), which previously has been linked to differences in the levels of HLA-G expression and in HLA-G mRNA splicing. The results may also indicate that combined mother-child HLA-G genotypes could influence the risk of developing pre-eclampsia. Overall, the study suggests that HLA-G genotypes and expression might have a significant influence on development of pre-eclampsia.

AB - Pre-eclampsia affects 2-7% of all pregnancies with varying severity and is a leading cause of maternal and fetal mortality and morbidity. The aetiology involves almost certainly a combination of genetic predisposition with maternal and fetal contributions and environmental factors. Research points towards pathologies in the placenta as the triggering factor which leads to systemic endothelial dysfunction in the mother, probably as the result of interaction with released placental factors circulating in the maternal blood. One prominent hypothesis regarding the aetiology of pre-eclampsia suggests that it is caused by immune- maladaptation. The MHC class Ib gene, HLA-G, is expressed in the placenta and seems to have immunomodulatory functions. Aberrant HLA-G mRNA and protein expression in pre-eclamptic placentas have been reported. Here, we have investigated detailed HLA-G genotypes in a case-control study of 155 family triads of mother, father and newborn. Among primiparas, an overrepresentation of a homozygous HLA-G genotype was detected in the 40 pre-eclamptic offspring compared to the 70 controls [P = 0.002, Fisher's exact test; odds ratio 5.57 (95% CI 1.79-17.31)]. Further analyses suggested that the differences between pre-eclamptic cases and controls primarily were accomplished by a different transmission from the father of a 14 bp deletion/insertion polymorphism in exon 8 (P = 0.006, Fisher's exact test), which previously has been linked to differences in the levels of HLA-G expression and in HLA-G mRNA splicing. The results may also indicate that combined mother-child HLA-G genotypes could influence the risk of developing pre-eclampsia. Overall, the study suggests that HLA-G genotypes and expression might have a significant influence on development of pre-eclampsia.

U2 - 10.1093/molehr/gah035

DO - 10.1093/molehr/gah035

M3 - Journal article

C2 - 14985477

VL - 10

SP - 237

EP - 246

JO - Molecular Human Reproduction

JF - Molecular Human Reproduction

SN - 1360-9947

IS - 4

ER -

ID: 21161970